Kwee-Tat Chew is Director, Regulatory Strategist, Strategic Drug Development, Quintiles Asia-Pacific. Kwee-Tat has more than 20 years of regulatory experience in Asia-Pacific. Prior to joining Quintiles, he held various regional regulatory affairs roles within Boehringer Ingelheim, Covance, Baxter, Abbott Diabetes Care, and Novartis Vaccines & Diagnostics.
At Abbott, Kwee-Tat led and supported local affiliates in 15 countries in Asia-Pacific, including Australia, China and Japan, on their regulatory affairs needs and project deliverables in the diabetes diagnostics area. In Quintiles, Kwee-Tat provides strategic regulatory inputs to help clients unlock new markets.